Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGurbuz, Melahat
dc.contributor.authorGencer, Gulcan
dc.date.accessioned2025-12-28T16:40:12Z
dc.date.available2025-12-28T16:40:12Z
dc.date.issued2024
dc.identifier.issn0025-7974
dc.identifier.issn1536-5964
dc.identifier.urihttps://doi.org/10.1097/MD.0000000000040783
dc.identifier.urihttps://hdl.handle.net/20.500.12933/2456
dc.description.abstractThe increasing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) poses a significant threat to public health. CRE, particularly Klebsiella pneumoniae, is associated with high morbidity and mortality owing to limited treatment options. This study identifies current research trends, major topics, and future directions in the scientific field of CRE. We systematically retrieved publications from the Web of Science database starting from 2020 to January 07, 2024. Using bibliometric tools such as VOSviewer, CiteSpace, and InCites, we analyzed publication counts, citation analysis, co-authorship, keyword co-occurrence, and thematic development to map the landscape and collaborative networks in the field. The search included keywords such as carbapenem-resistant Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae, carbapenemase-producing Klebsiella pneumoniae, and Klebsiella pneumoniae carbapenemase. We reviewed 1946 articles. The largest contributors to the field were China, the United States, and Italy. This study highlights the significant increase in CRE-related publications, particularly in the context of hospital-acquired infections, antimicrobial resistance mechanisms, and novel therapeutic approaches. Keyword trend analysis revealed epidemiology, molecular biology, infection control, and public health implications, signaling a shift towards the broader impact of CRE in healthcare settings. This bibliometric analysis maps the current research landscape and identifies key areas for further research. Continued progress is essential to develop strategies to combat antimicrobial resistance and to improve patient outcomes.
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofMedicine
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectantimicrobial resistance
dc.subjectcarbapenemase-producing Klebsiella pneumoniae
dc.subjectcarbapenem-resistant Enterobacteriaceae
dc.subjectinfection control
dc.subjectmolecular epidemiology
dc.subjectnosocomial infections
dc.titleGlobal trends and future directions on carbapenem-resistant Enterobacteriaceae (CRE) research: A comprehensive bibliometric analysis (2020-2024)
dc.typeArticle
dc.identifier.orcid0000-0001-6290-1216
dc.identifier.orcid0000-0002-3543-041X
dc.departmentAfyonkarahisar Sağlık Bilimleri Üniversitesi
dc.identifier.doi10.1097/MD.0000000000040783
dc.identifier.volume103
dc.identifier.issue49
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.department-temp[Gurbuz, Melahat] Afyonkarahisar Hlth Sci Univ, Fac Med, Dept Med Microbiol, Afyonkarahisar, Turkiye; [Gencer, Gulcan] Afyonkarahisar Hlth Sci Univ, Fac Med, Dept Biostat & Med Informat, Afyonkarahisar, Turkiye
dc.identifier.pmid39654218
dc.identifier.scopus2-s2.0-85211967874
dc.identifier.scopusqualityQ2
dc.identifier.wosWOS:001377183100015
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.snmzKA_WoS_20251227


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster